BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27155335)

  • 1. Loss of Akt increases soluble endoglin release from endothelial cells but not placenta.
    Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Brownfoot F; De Silva M; Cannon P; Tuohey L; Tong S
    Pregnancy Hypertens; 2016 Apr; 6(2):95-102. PubMed ID: 27155335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14.
    Kaitu'u-Lino TJ; Hastie R; Cannon P; Nguyen H; Lee S; Hannan NJ; Tong S
    Placenta; 2015 Aug; 36(8):932-7. PubMed ID: 26145228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells.
    Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T
    Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the PI3K-Akt pathway suppresses sFlt1 expression in human placental hypoxia models in vitro.
    Park JK; Jeong JW; Kang MY; Baek JC; Shin JK; Lee SA; Choi WS; Lee JH; Paik WY
    Placenta; 2010 Jul; 31(7):621-9. PubMed ID: 20488538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LIFR increases the release of soluble endoglin via the upregulation of MMP14 expression in preeclampsia.
    Li H; Yao J; Chang X; Wu J; Duan T; Wang K
    Reproduction; 2018 Mar; 155(3):297-306. PubMed ID: 29363569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1.
    Cudmore MJ; Ahmad S; Sissaoui S; Ramma W; Ma B; Fujisawa T; Al-Ani B; Wang K; Cai M; Crispi F; Hewett PW; Gratacós E; Egginton S; Ahmed A
    Eur Heart J; 2012 May; 33(9):1150-8. PubMed ID: 21411816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of TACC3 inhibits trophoblast cell migration and invasion through the PI3K/Akt signaling pathway.
    Zhu X; Cao Q; Li X; Wang Z
    Mol Med Rep; 2016 Oct; 14(4):3437-42. PubMed ID: 27572091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD97 Is Decreased in Preeclamptic Placentas and Promotes Human Trophoblast Invasion Through PI3K/Akt/mTOR Signaling Pathway.
    Shen H; Jin M; Gu S; Wu Y; Yang M; Hua X
    Reprod Sci; 2020 Aug; 27(8):1553-1561. PubMed ID: 32430705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MT-MMPs in pre-eclamptic placenta: relationship to soluble endoglin production.
    Kaitu'u-Lino TJ; Tuohey L; Ye L; Palmer K; Skubisz M; Tong S
    Placenta; 2013 Feb; 34(2):168-73. PubMed ID: 23261267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
    Kaitu'u-Lino TJ; Brownfoot FC; Hastie R; Chand A; Cannon P; Deo M; Tuohey L; Whitehead C; Hannan NJ; Tong S
    Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of receptor tyrosine kinase-like orphan receptor 1 in preeclampsia placenta inhibits human trophoblast cell proliferation, migration, and invasion by PI3K/AKT/mTOR pathway accommodation.
    Chen J; Yue C; Xu J; Zhan Y; Zhao H; Li Y; Ye Y
    Placenta; 2019 Jul; 82():17-24. PubMed ID: 31174622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram inhibits placental soluble FMS-like tyrosine kinase-1 and soluble endoglin secretion independent of the proteasome.
    Hastie R; Ye L; Hannan NJ; Brownfoot FC; Cannon P; Nguyen V; Tong S; Kaitu'u-Lino TJ
    Pregnancy Hypertens; 2018 Oct; 14():125-130. PubMed ID: 30527099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin.
    Kaitu'u-Lino TJ; Palmer KR; Whitehead CL; Williams E; Lappas M; Tong S
    Am J Pathol; 2012 Mar; 180(3):888-894. PubMed ID: 22296769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromodomain protein BRD4 is increased in human placentas from women with early-onset preeclampsia.
    Liong S; Barker G; Lappas M
    Reproduction; 2018 Jun; 155(6):573-582. PubMed ID: 29748248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulated miR-149-5p contributes to preeclampsia via modulating endoglin expression.
    Xiaobo 赵肖波 Z; Qizhi H; Zhiping W; Tao D
    Pregnancy Hypertens; 2019 Jan; 15():201-208. PubMed ID: 30713088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Tuohey L; Kaitu'u-Lino TJ
    Mol Cell Endocrinol; 2015 Sep; 413():202-8. PubMed ID: 26159901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.